444 related articles for article (PubMed ID: 23434068)
1. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs.
Lamouille S; Subramanyam D; Blelloch R; Derynck R
Curr Opin Cell Biol; 2013 Apr; 25(2):200-7. PubMed ID: 23434068
[TBL] [Abstract][Full Text] [Related]
2. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mesenchymal phenotype by MicroRNAs in cancer.
Yan J; Gumireddy K; Li A; Huang Q
Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
Migault M; Sapkota S; Bracken CP
Cell Mol Life Sci; 2022 Mar; 79(3):182. PubMed ID: 35278142
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
Zhao X; Lu Y; Nie Y; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
[TBL] [Abstract][Full Text] [Related]
7. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.
Guo F; Parker Kerrigan BC; Yang D; Hu L; Shmulevich I; Sood AK; Xue F; Zhang W
J Hematol Oncol; 2014 Mar; 7():19. PubMed ID: 24598126
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.
Stacy AJ; Craig MP; Sakaram S; Kadakia M
Oncotarget; 2017 Jan; 8(2):2114-2129. PubMed ID: 27924063
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
11. What we can learn from embryos to understand the mesenchymal-to-epithelial transition in tumor progression.
Bernardi Y; Strobl-Mazzulla PH
Biochem J; 2021 May; 478(9):1809-1825. PubMed ID: 33988704
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.
Bullock MD; Sayan AE; Packham GK; Mirnezami AH
Biol Cell; 2012 Jan; 104(1):3-12. PubMed ID: 22188537
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and signaling networks involved in epithelial-mesenchymal transition.
Musavi Shenas MH; Eghbal-Fard S; Mehrisofiani V; Abd Yazdani N; Rahbar Farzam O; Marofi F; Yousefi M
J Cell Physiol; 2019 May; 234(5):5775-5785. PubMed ID: 30417364
[TBL] [Abstract][Full Text] [Related]
17. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
19. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
